PMID- 16142858 OWN - NLM STAT- MEDLINE DCOM- 20051115 LR - 20151119 IS - 0315-162X (Print) IS - 0315-162X (Linking) VI - 32 IP - 9 DP - 2005 Sep TI - Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis. PG - 1666-72 AB - OBJECTIVE: Studies indicate the genetic, biological, and clinical heterogeneity of rheumatoid arthritis (RA). Recently the histological diversity of RA has been postulated. We investigated whether serum concentrations of interleukin 8 (IL-8), RANTES (regulated upon activation normal T cell expressed and secreted), and monocyte chemoattractant protein-1 (MCP-1) are correlated with histological appearance of the rheumatoid synovitis. METHODS: Using ELISA we assessed IL-8, RANTES, and MCP-1 concentrations in serum of 47 patients with RA and 30 patients with osteoarthritis (OA). RESULTS: Morphological analysis of synovial specimens distinguished 2 types of rheumatoid synovitis. Twenty-eight RA samples presented diffuse infiltrates of mononuclear cells with no specific microanatomical organization and were categorized as diffuse synovitis. In the remaining 19 specimens, classified as follicular synovitis, formation of lymphocytic follicles with germinal center-like structures was observed. Serum levels of studied chemokines were increased in patients with RA compared to the OA control group (p < 0.001 for all comparisons). Concentrations of IL-8, RANTES, and MCP-1 were highest in serum of RA patients with follicular synovitis in comparison with patients with diffuse synovitis (p < 0.01, p < 0.01, and p < 0.05, respectively) and could distinguish RA patients with these 2 histological disease patterns. Serum levels of chemokines correlated with markers of disease activity such as erythrocyte sedimentation rate, C-reactive protein concentrations, and Disease Activity Score. CONCLUSION: Distinct histological variants of rheumatoid synovitis associated with different serum levels of IL-8, RANTES, and MCP-1 reflect clinical activity of the disease and confirm the concept of RA heterogeneity. FAU - Klimiuk, Piotr Adrian AU - Klimiuk PA AD - Department of Rheumatology and Internal Diseases, Medical University of Bialystok, Bialystok, Poland. klimp@amb.edu.pl FAU - Sierakowski, Stanislaw AU - Sierakowski S FAU - Latosiewicz, Robert AU - Latosiewicz R FAU - Skowronski, Jan AU - Skowronski J FAU - Cylwik, Jacek Przemyslaw AU - Cylwik JP FAU - Cylwik, Bohdan AU - Cylwik B FAU - Chwiecko, Justyna AU - Chwiecko J LA - eng PT - Comparative Study PT - Journal Article PL - Canada TA - J Rheumatol JT - The Journal of rheumatology JID - 7501984 RN - 0 (Biomarkers) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CCL5) RN - 0 (Chemokines) RN - 0 (Interleukin-8) SB - IM MH - Adult MH - Aged MH - Arthritis, Rheumatoid/*blood/*pathology/physiopathology MH - Biomarkers/blood MH - Biopsy, Needle MH - Case-Control Studies MH - Chemokine CCL2/blood MH - Chemokine CCL5/blood MH - Chemokines/*blood/metabolism MH - Disease Progression MH - Female MH - Humans MH - Immunohistochemistry MH - Interleukin-8/blood MH - Male MH - Middle Aged MH - Probability MH - Prognosis MH - Reference Values MH - Risk Assessment MH - Sensitivity and Specificity MH - Severity of Illness Index MH - Synovitis/blood/*pathology/physiopathology EDAT- 2005/09/06 09:00 MHDA- 2005/11/16 09:00 CRDT- 2005/09/06 09:00 PHST- 2005/09/06 09:00 [pubmed] PHST- 2005/11/16 09:00 [medline] PHST- 2005/09/06 09:00 [entrez] AID - 0315162X-32-1666 [pii] PST - ppublish SO - J Rheumatol. 2005 Sep;32(9):1666-72.